OGDEN MANUFACTURING PLANT OPTIFLUX 200NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
|
Back to Search Results |
|
Model Number 0500320E |
Device Problem
Fluid/Blood Leak (1250)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/10/2022 |
Event Type
malfunction
|
Event Description
|
A user facility administrative assistant (aa) reported that a blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.Upon additional follow-up, a registered nurse (rn), clarified the dialyzer blood leak occurred on (b)(6)2022 and was an internal blood leak within the dialyzer housing.The rn confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested positive for the presence of blood.The rn also stated that fresenius bloodlines were used for treatment and confirmed no external blood leak was observed.The rn stated that there were no defects or damage seen on the dialyzer.Per rn the patient¿s blood was not returned and stated the estimated blood loss was 200cc.Immediately following the event, the patient was re-setup with new supplies on a different machine where the patient was able to complete treatment.The rn confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was no longer available to be returned for manufacturer evaluation.
|
|
Manufacturer Narrative
|
Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
|
|
Event Description
|
A user facility administrative assistant (aa) reported that a blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.Upon additional follow-up, a registered nurse (rn), clarified the dialyzer blood leak occurred on (b)(6)2022 and was an internal blood leak within the dialyzer housing.The rn confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested positive for the presence of blood.The rn also stated that fresenius bloodlines were used for treatment and confirmed no external blood leak was observed.The rn stated that there were no defects or damage seen on the dialyzer.Per rn the patient¿s blood was not returned and stated the estimated blood loss was 200cc.Immediately following the event, the patient was re-setup with new supplies on a different machine where the patient was able to complete treatment.The rn confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was no longer available to be returned for manufacturer evaluation.
|
|
Manufacturer Narrative
|
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.A lot history review was performed.There were two other complaints reported against the lot.There was one complaint for two cracked dialyzers, no patient involvement (no sample).A review of the production record was performed.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.There is no recall associated with this complaint.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas 2018-0171 (vision systems) and 2018-0161 (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
|
|
Search Alerts/Recalls
|
|
|